Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pittsburgh Research Institute is a clinical research organization and specialized trial site based in Sewickley, Pennsylvania, that focuses on advancing ophthalmic medicine. The institute conducts Phase 1 through Phase 4 clinical trials for a wide range of ocular conditions, including dry eye disease, age-related macular degeneration, and diabetic retinopathy. Equipped with state-of-the-art diagnostic technology and specialized vision testing facilities, the institute partners with global pharmaceutical and biotechnology companies to evaluate new therapeutic interventions. In addition to industry-sponsored trials, the institute participates in investigator-initiated research and biomarker studies to enhance the diagnosis and treatment of eye diseases. It serves as a key regional hub for ophthalmic research in the Western Pennsylvania area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pittsburgh Research Institute.